argenx

Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...

SHANGHAI, China / CAMBRIDGE, Massachusetts / AMSTERDAM, Netherlands — August 17, 2026 Zai Lab Limited and argenx announced positive...

Amsterdam, Netherlands, August 17, 2026 argenx SE announced positive topline results from the Phase 3 ALKIVIA study evaluating VYVGART...

Amsterdam, the Netherlands and Dallas, Texas – July 27, 2026 argenx has entered into a definitive agreement to acquire...

AMSTERDAM, Netherlands, June 3, 2026 argenx presented new clinical data at the European Alliance of Associations for Rheumatology (EULAR)...

AMSTERDAM, Netherlands, May 8, 2026 Argenx SE announced that the U.S. Food and Drug Administration (FDA) has approved a...